VIVORYON THERAPEUTICS AG Chart calendar Vivoryon Therapeutics AG
37fbc0aafc235ab3d95b.k5iKPG83uVLsmO42-AQj5HclSGV2sQWnc5dD8cthrNE.5M_pfStW2iGboJhvvXJsqUdgLhcny2r9Cv06koEqxYbe9sFUXF7tZKrquw~c1575bcc5204ac1b8d22efc2bc974049
Upcoming events on Vivoryon Therapeutics AG
Past events on Vivoryon Therapeutics AG
| 2024-04-15 | Van Lanschot Kempen Life Sciences Conference |
| 2024-02-28 | Investor Meeting |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-12-06 09:00 am | Q3 2023 Earnings Call |
| 2023-12-06 01:00 am | Q3 2023 Earnings Release |
| 2023-11-14 06:30 am | Jefferies London Healthcare Conference |
| 2023-11-05 | BIO Europe Conference |
| 2023-10-23 | Alzheimer Disease Conference |
| 2023-10-17 07:30 am | R&D Day - Key Opinion Leader |
| 2023-10-11 02:00 pm | Jefferies Inaugural Biotech CNS/Neuro Summit |
| 2023-09-15 07:00 am | Extraordinary Shareholders Meeting |
| 2023-09-07 09:00 am | Q2 2023 Earnings Call |
| 2023-09-07 01:00 am | Q2 2023 Earnings Release |
| 2023-07-15 | Alzheimer Association International Conference |
| 2023-06-21 07:00 am | Annual General Meeting |
| 2023-06-07 08:00 am | Jefferies Global Healthcare Conference |
| 2023-06-04 | BIO International Convention |
| 2023-05-16 05:44 am | BioEquity Europe Conference |
| 2023-05-16 01:00 am | Q1 2023 Earnings Release |
| 2023-04-24 | Kempen Life Sciences Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 | 0,00 | 0,00 0,00 - | 10,8 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million EUR | Released Forecast Spread | -7,68 | 0,00 | -15,9 -13,2 -20.65% | -12,6 -17,7 28.63% | -29,0 -19,8 -45.96% | -22,9 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | 0,00 | -16,0 -13,3 -20.84% | -12,8 -17,8 28.1% | -29,1 -20,3 -43.25% | -23,0 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 0,00 | -16,5 -13,3 -24.14% | -12,2 -18,3 33.21% | -28,4 -20,3 -39.75% | -23,0 |
|
Net income Million EUR | Released Forecast Spread | -7,74 | -7,82 | -16,5 -13,3 -24.14% | -12,7 -18,3 30.85% | -28,2 -19,3 -46.21% | -23,0 |
|
EPS EUR | Released Forecast Spread | -0,94 | -0,62 | -0,83 -0,67 -24.81% | -0,63 -0,92 31.52% | -1,28 -0,85 -50.59% | -0,93 |
| Announcement Date | 28/03/19 | 26/03/20 | 30/04/21 | 28/04/22 | 19/04/23 | - |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 | |
|
EBIT Million EUR | Released Forecast Spread | -3,08 -2,24 -37.67% | -12,6 | |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -13,0 | ||
|
Net income Million EUR | Released Forecast Spread | -10,7 | -13,1 | |
|
EPS EUR | Released Forecast Spread | -0,44 | -0,50 | |
| Announcement Date | 30/07/19 | 07/09/23 | - |
More events
Past sector events for Vivoryon Therapeutics AG
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
